Publications

Clinical Research

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.Bejon P, Kai OK, Mwacharo J, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Eur J Immunol, (2006). 36:2264-72

Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.Ndiritu M, Cowgill KD, Ismail A, Chiphatsi S, Kamau T, Fegan G, Feikin DR, Newton CR, Scott JA
BMC Public Health, (2006). 6:132

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.Bejon P, Mwacharo J, Kai OK, Todryk S, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Vaccine, (2006). 24:4709-15

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, Lang T, Hill AV, Marsh K
Clin Infect Dis, (2006). 42:1102-10

Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network.Taylor T, Olola C, Valim C, Agbenyega T, Kremsner P, Krishna S, Kwiatkowski D, Newton C, Missinou M, Pinder M, Wypij D
Trans R Soc Trop Med Hyg, (2006). 100:615-22

Research priorities in the management of severe Plasmodium falciparum malaria in children.Idro R, Aketch S, Gwer S, Newton CR, Maitland K
Ann Trop Med Parasitol, (2006). 100:95-108

Are laboratory services coming of age in sub-Saharan Africa?.Bates I, Maitland K
Clin Infect Dis, (2006). 42:383-4

Risk factors for persisting neurological and cognitive impairments following cerebral malaria.Idro R, Carter JA, Fegan G, Neville BG, Newton CR
Arch Dis Child, (2006). 91:142-8

Attitudes and practices of families and health care personnel toward children with epilepsy in Kilifi, Kenya.El Sharkawy G, Newton C, Hartley S
Epilepsy Behav, (2006). 8:201-12

Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions.Sasi P, English M, Berkley J, Lowe B, Shebe M, Mwakesi R, Kokwaro G
Trans R Soc Trop Med Hyg, (2006). 100:401-9

Chloramphenicol pharmacokinetics in African children with severe malaria.Kokwaro GO, Muchohi SN, Ogutu BR, Newton CR
J Trop Pediatr, (2006). 52:239-43

Antibiotics for children with septicaemia in hospitals with limited resources..Berkley JA, Lowe BS, English M, Scott JAG
J Trop Pediatr, (2006). 52:46-48

Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria.Idro R, Otieno G, White S, Kahindi A, Fegan G, Ogutu B, Mithwani S, Maitland K, Neville BG, Newton CR
Malar J, (2005). 4:57

Pathogenesis, clinical features, and neurological outcome of cerebral malaria.Idro R, Jenkins NE, Newton CR
Lancet Neurol, (2005). 4:827-40

Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya.Gordon AL, English M, Tumaini Dzombo J, Karisa M, Newton CR
Trop Med Int Health, (2005). 10:1114-20

Issues in the development of cross-cultural assessments of speech and language for children.Carter JA, Lees JA, Murira GM, Gona J, Neville BG, Newton CR
Int J Lang Commun Disord, (2005). 40:385-401

The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters.Newton CR, Valim C, Krishna S, Wypij D, Olola C, Agbenyega T, Taylor TE
Clin Infect Dis, (2005). 41:948-57

Intravenous fluids--getting the balance right.Molyneux EM, Maitland K
N Engl J Med, (2005). 353:941-4

Determination of lorazepam in plasma from children by high-performance liquid chromatography with UV detection.Muchohi SN, Obiero K, Kokwaro GO, Ogutu BR, Githiga IM, Edwards G, Newton CR
J Chromatogr B Analyt Technol Biomed Life Sci, (2005). 824:333-40

Withdrawal of parenteral phenobarbitone--implications for resource-poor countries.Wilmshurst JM, van Toorn R, Newton CR
S Afr Med J, (2005). 95:422-3